Category: Drug Discovery
Drug Discovery market research reports by Icon Group International, Inc.
-
The 2025-2030 World Outlook for Psoriatic Arthritis Therapeutics
The 2025-2030 World Outlook for Psoriatic Arthritis Therapeutics This study covers the world outlook for psoriatic arthritis therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in que ... Read More
-
The 2025-2030 World Outlook for Intravenous Immunoglobulin for Guillain-Barre Syndromes
The 2025-2030 World Outlook for Intravenous Immunoglobulin for Guillain-Barre Syndromes This study covers the world outlook for intravenous immunoglobulin for guillain-Barre syndromes across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential indu ... Read More
-
The 2025-2030 World Outlook for Mutation-Suppression Duchenne Muscular Dystrophy Drugs
The 2025-2030 World Outlook for Mutation-Suppression Duchenne Muscular Dystrophy Drugs This study covers the world outlook for mutation-suppression Duchenne muscular dystrophy drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential indust ... Read More
-
The 2025-2030 World Outlook for Myasthenia Gravis Drugs
The 2025-2030 World Outlook for Myasthenia Gravis Drugs This study covers the world outlook for myasthenia gravis drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions ... Read More
-
The 2025-2030 World Outlook for Myeloproliferative Disorder Drugs
The 2025-2030 World Outlook for Myeloproliferative Disorder Drugs This study covers the world outlook for myeloproliferative disorder drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in q ... Read More
-
The 2025-2030 World Outlook for HIV Therapeutics
The 2025-2030 World Outlook for HIV Therapeutics This study covers the world outlook for HIV therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dolla ... Read More
-
The 2025-2030 World Outlook for Mouth Ulcer Drugs
The 2025-2030 World Outlook for Mouth Ulcer Drugs This study covers the world outlook for mouth ulcer drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dol ... Read More
-
The 2025-2030 World Outlook for Multiple Myeloma Treatments
The 2025-2030 World Outlook for Multiple Myeloma Treatments This study covers the world outlook for multiple myeloma treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in ... Read More
-
The 2025-2030 World Outlook for Respiratory Drugs
The 2025-2030 World Outlook for Respiratory Drugs This study covers the world outlook for respiratory drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dol ... Read More
-
The 2025-2030 World Outlook for Multiple Sclerosis Drugs
The 2025-2030 World Outlook for Multiple Sclerosis Drugs This study covers the world outlook for multiple sclerosis drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millio ... Read More
-
The 2025-2030 World Outlook for Photodynamic Therapies
The 2025-2030 World Outlook for Photodynamic Therapies This study covers the world outlook for photodynamic therapies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions o ... Read More
-
The 2025-2030 World Outlook for End Stage Renal Diseases
The 2025-2030 World Outlook for End Stage Renal Diseases This study covers the world outlook for end stage renal diseases across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millio ... Read More
-
The 2025-2030 World Outlook for Psoriasis Medicines
The 2025-2030 World Outlook for Psoriasis Medicines This study covers the world outlook for psoriasis medicines across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. ... Read More
-
The 2025-2030 World Outlook for Dermatophytic Onychomycosis Therapeutics
The 2025-2030 World Outlook for Dermatophytic Onychomycosis Therapeutics This study covers the world outlook for dermatophytic onychomycosis therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for th ... Read More
-
The 2025-2030 World Outlook for Narcolepsy Drugs
The 2025-2030 World Outlook for Narcolepsy Drugs This study covers the world outlook for narcolepsy drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dolla ... Read More
-
The 2025-2030 World Outlook for Substance Abuse Therapeutics
The 2025-2030 World Outlook for Substance Abuse Therapeutics This study covers the world outlook for substance abuse therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (i ... Read More
-
The 2025-2030 World Outlook for RNA-Based Therapeutics
The 2025-2030 World Outlook for RNA-Based Therapeutics This study covers the world outlook for RNA-based therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions o ... Read More
-
The 2025-2030 World Outlook for Hepatitis C Treatments
The 2025-2030 World Outlook for Hepatitis C Treatments This study covers the world outlook for hepatitis c treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions o ... Read More
-
The 2025-2030 World Outlook for RNA Therapeutics
The 2025-2030 World Outlook for RNA Therapeutics This study covers the world outlook for RNA therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dolla ... Read More
-
The 2025-2030 World Outlook for Cardiovascular Therapeutics
The 2025-2030 World Outlook for Cardiovascular Therapeutics This study covers the world outlook for cardiovascular therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in ... Read More
-
The 2025-2030 World Outlook for Cancer Supportive Care Therapeutics
The 2025-2030 World Outlook for Cancer Supportive Care Therapeutics This study covers the world outlook for cancer supportive care therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country ... Read More
-
The 2025-2030 World Outlook for Cancer-Treating Drugs
The 2025-2030 World Outlook for Cancer-Treating Drugs This study covers the world outlook for cancer-treating drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of ... Read More
-
The 2025-2030 World Outlook for Autism Spectrum Disorder Therapeutics
The 2025-2030 World Outlook for Autism Spectrum Disorder Therapeutics This study covers the world outlook for autism spectrum disorder therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the coun ... Read More
-
The 2025-2030 World Outlook for Autism Therapies
The 2025-2030 World Outlook for Autism Therapies This study covers the world outlook for autism therapies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dolla ... Read More
-
The 2025-2030 World Outlook for Uveitis Drugs
The 2025-2030 World Outlook for Uveitis Drugs This study covers the world outlook for uveitis drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), t ... Read More
Research Assistance
